Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson’s and Alzheimer’s Disease
Sachchida Nand, Neeraj Tiwari, Payal Singh, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective
Kakarla Ramakrishna, Lakshmi Vineela Nalla, Naresh Dumala, et al.
Diseases (2023) Vol. 11, Iss. 3, pp. 89-89
Open Access | Times Cited: 98
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharis C. Theoharides, Duraisamy Kempuraj
Cells (2023) Vol. 12, Iss. 5, pp. 688-688
Open Access | Times Cited: 53
Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease
Chunmei Ma, Ying Liu, Sheng Li, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 7, pp. 2018-2035
Open Access | Times Cited: 28
An update on pathogenesis and clinical scenario for Parkinson’s disease: diagnosis and treatment
Hussaini Adam, Subash C. B. Gopinath, M. K. Md Arshad, et al.
3 Biotech (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 27
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders
Fabiola De Marchi, Ivana Munitić, Lea Vidatic, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2793-2793
Open Access | Times Cited: 26
Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites
Ziying Jiang, Xinyu Wang, Haoqiang Zhang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 23
Drug repositioning for Parkinson’s disease: an emphasis on artificial intelligence approaches
Iman Karimi-Sani, Mehrdad Sharifi, Nahid Abolpour, et al.
Ageing Research Reviews (2025) Vol. 104, pp. 102651-102651
Closed Access | Times Cited: 1
Exploring the Therapeutic Effect of Neurotrophins and Neuropeptides in Neurodegenerative Diseases: at a Glance
Md. Mominur Rahman, Md. Rezaul Islam, Fatema Akter Supti, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4206-4231
Closed Access | Times Cited: 22
Inhibition of VDAC1 Rescues Aβ1-42-Induced Mitochondrial Dysfunction and Ferroptosis via Activation of AMPK and Wnt/β-Catenin Pathways
Xinpei Zhou, Ximin Tang, Tao Li, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 20
Aromatherapy for the brain: Lavender's healing effect on epilepsy, depression, anxiety, migraine, and Alzheimer's disease: A review article
Nazanin Hatami Bavarsad, Shokufeh Bagheri, Masoumeh Kourosh‐Arami, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e18492-e18492
Open Access | Times Cited: 20
Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review
Trevor J. Plowman, Hannah Christensen, Myia Aiges, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5190-5190
Open Access | Times Cited: 8
Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6389-6389
Open Access | Times Cited: 8
Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR signaling
Rehab M. El‐Sayed, Ahmed M Abdelaziz, Hala F. Zaki, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109986-109986
Closed Access | Times Cited: 16
COVID-19 delirium and encephalopathy: Pathophysiology assumed in the first 3 years of the ongoing pandemic
Kyohei Otani, Haruko Fukushima, Kunitaka Matsuishi
Brain Disorders (2023) Vol. 10, pp. 100074-100074
Open Access | Times Cited: 16
Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF‐KB pathway
Jing Lv, Jing Zhu, Peihan Wang, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 4, pp. 1012-1023
Open Access | Times Cited: 15
Role of Inflammation in the Development of COVID-19 to Parkinson’s Disease
Tingting Liu, Haojie Wu, Lin Sun, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3259-3282
Open Access | Times Cited: 5
Dantrolene and ryanodine receptors in COVID‐19: The daunting task and neglected warden
Luay Alkazmi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 5, pp. 335-352
Closed Access | Times Cited: 11
Reactive gliosis and neuroinflammation: prime suspects in the pathophysiology of post-acute neuroCOVID-19 syndrome
Jacob Saucier, Dominique Comeau, Gilles A. Robichaud, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 11
Ginkgo biloba and Its Chemical Components in the Management of Alzheimer’s Disease
Yong Peng, Quan Chen, Yahui Xue, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 03, pp. 625-666
Closed Access | Times Cited: 4
SARS-CoV-2: A synergy to the Alzheimer’s disease
Khaja Moinuddin Shaik, Deepak Kumar, Pirangi Srikanth, et al.
Journal of NeuroVirology (2025)
Closed Access
Structural and Functional Impacts of SARS-CoV-2 Spike Protein Mutations: Insights from Predictive Modeling and Analytics (Preprint)
Edem K. Netsey, Samuel M. Naandam, Joseph Jr. Asante, et al.
(2025)
Closed Access
Bioinformatic Analysis of Genetic Factors from Human Blood Samples and Postmortem Brains in Parkinson’s Disease
Longping Yao, Kai Lin, Zijian Zheng, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 18
Epidemiology, pathophysiology, transmission, genomic structure, treatment, and future perspectives of the novel Marburg virus outbreak
Md. Rezaul Islam, Shopnil Akash, Md. Mominur Rahman, et al.
International Journal of Surgery (2023) Vol. 109, Iss. 1, pp. 36-38
Open Access | Times Cited: 10
An unprecedented global challenge, emerging trends and innovations in the fight against COVID-19: A comprehensive review
S. Moneshwaran, D. Macrin, N. Kanagathara
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131324-131324
Closed Access | Times Cited: 3
Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19
Jia‐You Fang, Kuo‐Yen Huang, Tong‐Hong Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top